Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Teladoc (DE:4LL)
MUNICH:4LL
Teladoc (4LL) Stock Price & Analysis
4 Followers
4LL Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€11.85 - €27.42
Previous Close€12.6
Volume0.00
Average Volume (3M)869.00
Market Cap
€2.06B
Enterprise Value€2.49B
Total Cash (Recent Filing)$1.12B
Total Debt (Recent Filing)$1.58B
Price to Earnings (P/E)N/A
Beta1.54
Next Earnings
Jul 23, 2024EPS Estimate
-€0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume869
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.96
Enterprise Value/Gross Profit1.35
Enterprise Value/Ebitda16.03
Forecast
1Y Price Target
€17.27Price Target Upside40.77% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering21
Teladoc News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTeladoc's first quarter results exceeded market expectations, showcasing the company's ability to outperform.
Growth StrategyWith significant growth in US Integrated Care members, Teladoc is well-positioned to enhance revenue through cross-selling and expansion strategies.
Product ExpansionTeladoc has expanded its weight management program, providing a more comprehensive approach to care and addressing a growing demand in health management.
Bears Say
Company GuidanceTeladoc offered 2Q guidance below consensus, indicating potential short-term challenges ahead.
Management ChangesRecent management changes have heightened execution risk for the company.
Revenue ConcernsThe BetterHelp segment's expected revenue decline due to persistent adverse trends in advertising yield.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
14.20% Other Institutional Investors
85.80% Public Companies and
Individual Investors
4LL FAQ
What was Teladoc’s price range in the past 12 months?
Teladoc lowest stock price was €11.85 and its highest was €27.42 in the past 12 months.
What is Teladoc’s market cap?
Currently, no data Available
When is Teladoc’s upcoming earnings report date?
Teladoc’s upcoming earnings report date is Jul 23, 2024 which is in 82 days.
How were Teladoc’s earnings last quarter?
Teladoc released its earnings results on Apr 25, 2024. The company reported -€0.458 earnings per share for the quarter, missing the consensus estimate of -€0.429 by -€0.029.
Is Teladoc overvalued?
According to Wall Street analysts Teladoc’s price is currently Undervalued.
Does Teladoc pay dividends?
Teladoc does not currently pay dividends.
What is Teladoc’s EPS estimate?
Teladoc’s EPS estimate is -€0.31.
How many shares outstanding does Teladoc have?
Currently, no data Available
What happened to Teladoc’s price movement after its last earnings report?
Teladoc reported an EPS of -€0.458 in its last earnings report, missing expectations of -€0.429. Following the earnings report the stock price went up 0.079%.
Which hedge fund is a major shareholder of Teladoc?
Among the largest hedge funds holding Teladoc’s share is ARK Investment Management LLC. It holds Teladoc’s shares valued at 457M.
---
Teladoc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€17.27 (40.77% Upside)
€17.27 (40.77% Upside)
Blogger Sentiment
Bullish
DE:4LL Sentiment 78%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $5.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-49.52%
12-Months-Change
Fundamentals
Return on Equity
-10.18%
Trailing 12-Months
Asset Growth
0.27%
Trailing 12-Months
Company Description
Teladoc
Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company. The company provides telehealth solutions, expert medical services, medical opinions, artificial intelligence and analytics, behavioral health solutions, guidance and support, and platform and program services.
---
4LL Company Deck
---
4LL Earnings Call
Q1 2024
0:00 / 0:00
---
4LL Revenue Breakdown
87.71% Access Fees Revenue
12.29% Other
---
4LL Stock 12 Months Forecast
Average Price Target
€17.27
▲(40.77% Upside)
Technical Analysis
Best Analysts Covering 4LL
1 Year
1 Year Success Rate
23/42 ratings generated profit
1 Year Average Return
+24.84%
reiterated a buy rating 7 days ago
Copying Richard Close's trades and holding each position for 1 Year would result in 54.76% of your transactions generating a profit, with an average return of +24.84% per trade.
---